|Fulfilling our mission
Our sole beneficiary is the National Heart & Lung Institute (NHLI) which is devoted to research, education and patient care in heart, lung and cardiovascular diseases. Click here to open the Institiute's website for the most up to date news and information about their work https://www.imperial.ac.uk/nhli
As a Foundation we believe that by supporting the work of the NHLI we, with your help, can best fulfil our mission.
Today the National Heart and Lung Institute (NHLI) is based at sites on the Royal Brompton, Harefield, Hammersmith, St Mary’s and South Kensington campuses. The NHLI maintains close links to the Royal Brompton and Harefield NHS Foundation Trust, which was awarded two Biomedical Research Units (Cardiovascular and Respiratory) by the National Institute of Health Research (NIHR), and the Imperial College Healthcare NHS Trust, home to the largest NIHR Biomedical Research Centre in the UK. Together these comprise the Academic Health Sciences System (AHSS).
According to the Rand analysis (2004 to 2013) Imperial is the top university in the UK in three specialities: respiratory, cardiovascular and gastroenterological, in that order. If we look specifically at the highly cited papers, Imperial College is ranked first in three areas, which importantly for NHLI include respiratory disease (13.6% of the total) and cardiovascular disease (8.8%) and these figures significantly increase when the Royal Brompton and Imperial College Health Trusts, where a significant number of NHLI associates are based, are included.
The national burden of heart and lung disease is immense. It causes unquantifiable misery and almost every family has a member, friend or colleague who has died or suffered from heart and lung disease.
The Foundation is able to support the Institute in reaching out and touching the lives of so many people of all ages.